ASRA Guidelines for Epidural Insertion, Removal, and Anticoagulant/Antiplatelet Timing
Follow the specific time intervals outlined in the Association of Anaesthetists guidelines (which incorporate ASRA recommendations) for epidural procedures with anticoagulants and antiplatelets to minimize the risk of vertebral canal hematoma, a catastrophic complication with an incidence of approximately 0.85 per 100,000 neuraxial blocks. 1
Key Timing Intervals for Epidural Insertion
Anticoagulants
Heparins:
- UFH subcutaneous prophylaxis: Wait 4 hours or until normal APTTR before insertion 1
- UFH intravenous treatment: Wait 4 hours or until normal APTTR before insertion 1
- LMWH prophylactic dose: Wait 12 hours after last dose before insertion 1
- LMWH treatment dose: Wait 24 hours after last dose before insertion 1
Direct Oral Anticoagulants (DOACs):
- Rivaroxaban prophylaxis: Wait 18 hours after last dose 1
- Rivaroxaban treatment: Wait 48 hours after last dose 1
- Dabigatran (CrCl >80 mL/min): Wait 48 hours after last dose 1
- Dabigatran (CrCl 50-80 mL/min): Wait 72 hours after last dose 1
- Dabigatran (CrCl 30-50 mL/min): Wait 96 hours after last dose 1
- Apixaban prophylaxis: Wait 24-48 hours after last dose 1
Warfarin:
- Wait until INR ≤ 1.4 before insertion 1
Other Anticoagulants:
- Fondaparinux prophylaxis: Wait 36-42 hours (consider anti-Xa levels) 1
- Fondaparinux treatment: Avoid neuraxial procedures (consider anti-Xa levels if necessary) 1
Antiplatelet Agents
P2Y12 Inhibitors:
- Clopidogrel: Wait 7 days before insertion 1
- Prasugrel: Wait 7 days before insertion 1
- Ticagrelor: Wait 5 days before insertion 1
GP IIb/IIIa Inhibitors:
- Tirofiban: Wait 8 hours before insertion 1
- Eptifibatide: Wait 8 hours before insertion 1
- Abciximab: Wait 48 hours before insertion 1
Other Antiplatelet Drugs:
- Aspirin: No additional precautions required 1
- NSAIDs: No additional precautions required 1
- Dipyridamole: No additional precautions required 1
Catheter Removal Timing
The timing of epidural catheter removal follows similar principles to insertion, as the risk of epidural hematoma exists at both insertion and removal. 1
Time After Last Anticoagulant Dose Before Catheter Removal
- UFH subcutaneous prophylaxis: 4 hours or normal APTTR 1
- UFH intravenous treatment: 4 hours or normal APTTR 1
- LMWH prophylaxis: 12 hours 1
- LMWH treatment: 24 hours 1
- Rivaroxaban prophylaxis: 18 hours 1
- Rivaroxaban treatment: 48 hours 1
- Dabigatran: 48-96 hours (depending on renal function) 1
- Apixaban prophylaxis: 24-48 hours 1
- Warfarin: INR ≤ 1.4 1
- Clopidogrel/Prasugrel: 7 days 1
- Ticagrelor: 5 days 1
Post-Removal Drug Resumption
After epidural catheter removal, specific time intervals must elapse before resuming anticoagulants or antiplatelets to allow hemostasis at the puncture site. 1
Time After Catheter Removal Before Next Drug Dose
Anticoagulants:
- UFH subcutaneous prophylaxis: 1 hour 1
- UFH intravenous treatment: 4 hours (with caution in cardiac/vascular surgery) 1
- LMWH prophylaxis: 4 hours (consider 24 hours if traumatic insertion) 1
- LMWH treatment: 4 hours 1
- Rivaroxaban (prophylaxis or treatment): 6 hours 1
- Dabigatran: 6 hours 1
- Apixaban: 6 hours 1
- Warfarin: After catheter removal (no specific time given) 1
- Fondaparinux prophylaxis: 6-12 hours 1
- Fondaparinux treatment: 12 hours 1
Antiplatelet Agents:
- Aspirin: No additional precautions 1
- NSAIDs: No additional precautions 1
- Clopidogrel/Prasugrel/Ticagrelor: 6 hours 1
- GP IIb/IIIa inhibitors: 6 hours 1
- Dipyridamole: 6 hours 1
Critical Considerations While Catheter Is In Situ
Administration of anticoagulants while an epidural catheter is in place carries significant risk and is generally not recommended for most agents. 1
Drugs Allowed with Caution:
- UFH subcutaneous prophylaxis: Caution acceptable 1
- UFH intravenous treatment: Caution acceptable (common in cardiac/vascular surgery with local protocols) 1
- LMWH prophylaxis: Caution acceptable (many clinicians recommend only one dose in first 24 hours after neuraxial blockade) 1
- Aspirin and NSAIDs: No additional precautions 1
- Dipyridamole: No additional precautions 1
Drugs NOT Recommended While Catheter In Situ:
- LMWH treatment doses 1
- All DOACs (rivaroxaban, dabigatran, apixaban) 1
- Warfarin 1
- P2Y12 inhibitors (clopidogrel, prasugrel, ticagrelor) 1
- GP IIb/IIIa inhibitors 1
- Fondaparinux 1
- All thrombolytic drugs 1
Special Circumstances and Pitfalls
Traumatic needle/catheter placement increases bleeding risk and may warrant extending the time interval before resuming LMWH prophylaxis from 4 hours to 24 hours. 1
Renal impairment significantly affects DOAC clearance, particularly dabigatran, requiring substantially longer waiting periods based on creatinine clearance. 1
Recent evidence suggests that anti-Xa levels may remain elevated beyond the recommended 24-hour interval after treatment-dose enoxaparin, with 11 of 19 patients showing elevated levels despite meeting time-based guidelines. 2 This raises concerns about whether time-based recommendations alone are sufficiently conservative, though routine anti-Xa monitoring is not currently recommended by guidelines. 2
For patients who develop acute coronary syndromes requiring emergent antiplatelet therapy while an epidural catheter is in situ, immediate catheter removal is critical, as maximal platelet inhibition occurs within 30 minutes for ticagrelor and 4-6 hours for clopidogrel. 3
Thrombolytic drugs require a 10-day interval both before insertion and after catheter removal, representing the longest waiting period of any medication class. 1
Manufacturer recommendations for DOACs often advise against neuraxial catheter use entirely (particularly for dabigatran), though clinical guidelines provide specific timing intervals when procedures are deemed necessary. 1